EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 2, 2010, Pages 443-450

  Darcourt, Jacques ^a,k   Booij, Jan ^b   Tatsch, Klaus ^c   Varrone, Andrea ^d   Vander Borght, Thierry ^e   Kapucu, Özlem L ^f   Någren, Kjell ^g   Nobili, Flavio ^h   Walker, Zuzana ⁱ   Van Laere, Koen ^j  

^a CENTRE ANTOINE LACASSAGNE   (France)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Municipal Hospital Karlsruhe   (Germany)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

^f GAZI UNIVERSITY   (Turkey)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

^h UNIVERSITY OF GENOA   (Italy)

ⁱ UNIVERSITY COLLEGE LONDON   (United Kingdom)

^j UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^k UNIVERSITÉ CÔTE D'AZUR   (France)

more..

Author keywords

Brain; DAT; Parkinson; SPECT

Indexed keywords

2BETA CARBOXYMETHOXY 3BETA (4 IODOPHENYL)TROPANE IODINE 123; DOPAMINE TRANSPORTER; IODINE 123; N OMEGA FLUOROPROPYL 2BETA CARBOMETHOXY 3BETA (4-IODOPHENYL)NORTROPANE IODINE 123; RADIOISOTOPE; UNCLASSIFIED DRUG;

DOSIMETRY; EXPERIENCE; HUMAN; ISOTOPE LABELING; NEUROIMAGING; NEUROTRANSMISSION; NUCLEAR MEDICINE; PARKINSONISM; PHYSICIAN; PRACTICE GUIDELINE; RADIATION DOSE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

BRAIN; DOPAMINE; EUROPEAN UNION; FEMALE; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; PRACTICE GUIDELINES AS TOPIC; RADIOPHARMACEUTICALS; RECEPTORS, DOPAMINE D2; SYNAPTIC TRANSMISSION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77949266557     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1267-x     Document Type: Review

References (33)

1. K Tatsch S Asenbaum P Bartenstein A Catafau C Halldin LS Pilowsky, et al. 2002 European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) transporter ligands Eur J Nucl Med Mol Imaging 29 10 BP30 BP35 1:STN:280:DC%2BD38nntl2rtQ%3D%3D 12436496
2. P Bartenstein F Grunwald T Kuwert K Tatsch O Sabri O Benkert, et al. 2000 Clinical applications of single photon emission tomography in neuromedicine. 1. Neuro-oncology, epilepsy, movement disorders, cerebrovascular disease Nuklearmedizin 39 7 180 195 1:STN:280:DC%2BD3M%2FosVCltw%3D%3D 11127047 (Pubitemid 30947687)
3. P Payoux JL Baulieu J Darcourt E Guedj MO Habert C Prunier, et al. 2008 Guide pour la rédaction de protocoles pour la scintigraphie à l'aide de ligands des transporteurs présynaptiques de la dopamine dans le striatum Médecine Nucléaire 32 623 625 10.1016/j.mednuc.2008.06. 007
4. AM Catafau 2001 Brain SPECT of dopaminergic neurotransmission: a new tool with proved clinical impact Nucl Med Commun 22 10 1059 1060 10.1097/00006231-200110000-00001 1:STN:280:DC%2BD3MritVWhsg%3D%3D 11567176 (Pubitemid 33015969)
5. C Halldin B Gulyas O Langer L Farde 2001 Brain radioligands - state of the art and new trends Q J Nucl Med 45 2 139 152 1:STN:280: DC%2BD3MvivVGhtw%3D%3D 11476163
6. K Tatsch 2001 Imaging of the dopaminergic system in parkinsonism with SPET Nucl Med Commun 22 7 819 827 10.1097/00006231-200107000-00015 1:CAS:528:DC%2BD3MXlsFShurc%3D 11453057 (Pubitemid 32613445)
7. DaTSCAN European Public Assessment Report. 072200en6.pdf and DaTSCAN-H-266-AR-II.pdf, http://www.emea.europa.eu/humandocs/Humans/EPAR/ datscan/Datscan.htm.
8. TS Benamer J Patterson DG Grosset J Booij K de Bruin E van Royen, et al. 2000 Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group Mov Disord 15 3 503 510 10.1002/1531-8257(200005)15:3<503::AID-MDS1013>3.0. CO;2-V 1:STN:280:DC%2BD3cvnsVSntw%3D%3D 10830416 (Pubitemid 30333223)
9. J Booij TG Hemelaar JD Speelman K de Bruin AG Janssen EA van Royen 1999 One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT J Nucl Med 40 5 753 761 1:CAS:528:DyaK1MXjsVamur8%3D 10319746
10. C Scherfler J Schwarz A Antonini D Grosset F Valldeoriola K Marek, et al. 2007 Role of DAT-SPECT in the diagnostic work up of parkinsonism Mov Disord 22 9 1229 1238 10.1002/mds.21505 17486648 (Pubitemid 47325028)
11. AM Vlaar MJ van Kroonenburgh AG Kessels WE Weber 2007 Meta-analysis of the literature on diagnostic accuracy of SPECT in parkinsonian syndromes BMC Neurol 7 27 10.1186/1471-2377-7-27 17764571 (Pubitemid 350066529)
12. I McKeith J O'Brien Z Walker K Tatsch J Booij J Darcourt, et al. 2007 Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study Lancet Neurol 6 4 305 313 10.1016/S1474-4422(07)70057-1 17362834 (Pubitemid 46367938)
13. JT O'Brien S Colloby J Fenwick ED Williams M Firbank D Burn, et al. 2004 Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies Arch Neurol 61 6 919 925 10.1001/archneur.61.6.919 15210531 (Pubitemid 38747333)
14. Z Walker E Jaros RW Walker L Lee DC Costa G Livingston, et al. 2007 Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy J Neurol Neurosurg Psychiatry 78 11 1176 1181 10.1136/jnnp.2006.110122 17353255 (Pubitemid 350057277)
15. J Booij G Tissingh GJ Boer JD Speelman JC Stoof AG Janssen, et al. 1997 [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease J Neurol Neurosurg Psychiatry 62 2 133 140 10.1136/jnnp.62.2.133 1:STN:280:DyaK2s3gtVyrsQ%3D%3D 9048712
16. KL Marek JP Seibyl SS Zoghbi Y Zea-Ponce RM Baldwin B Fussell, et al. 1996 [123I]beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease Neurology 46 1 231 237 1:STN:280:DyaK287ktlWqtg%3D%3D 8559382
17. HT Benamer J Patterson DJ Wyper DM Hadley GJ Macphee DG Grosset 2000 Correlation of Parkinson's disease severity and duration with 123I-FP-CIT SPECT striatal uptake Mov Disord 15 4 692 698 10.1002/1531-8257(200007)15:4<692:: AID-MDS1014>3.0.CO;2-V 1:STN:280:DC%2BD3M%2FotlWqsg%3D%3D 10928580 (Pubitemid 30479622)
18. K Marek R Innis C van Dyck B Fussell M Early S Eberly, et al. 2001 [123I]{beta}-CIT SPECT imaging assessment of the rate of Parkinson's disease progression Neurology 57 11 2089 2094 1:STN:280:DC%2BD3MjgtFCrsA%3D%3D 11739831
19. J Booij P Kemp 2008 Dopamine transporter imaging with [(123)I]FP-CIT SPECT: potential effects of drugs Eur J Nucl Med Mol Imaging 35 2 424 438 10.1007/s00259-007-0621-0 1:CAS:528:DC%2BD1cXosVeisQ%3D%3D 17968545
20. YK Yang WJ Yao TL Yeh IH Lee PS Chen RB Lu, et al. 2008 Decreased dopamine transporter availability in male smokers-a dual isotope SPECT study Prog Neuropsychopharmacol Biol Psychiatry 32 1 274 279 10.1016/j.pnpbp.2007.08. 018 1:CAS:528:DC%2BD1cXptlajug%3D%3D 17900774
21. O Schillaci M Pierantozzi L Filippi C Manni L Brusa R Danieli, et al. 2005 The effect of levodopa therapy on dopamine transporter SPECT imaging with 123I-FP-CIT in patients with Parkinson's disease Eur J Nucl Med Mol Imaging 32 12 1452 10.1007/s00259-005-1922-9 1:CAS:528:DC%2BD2MXht1ygu7%2FO 16151764 (Pubitemid 41746850)
22. S Fahn D Oakes I Shoulson K Kieburtz A Rudolph A Lang The Parkinson Study G, et al. 2004 Levodopa and the progression of Parkinson's disease N Engl J Med 351 24 2498 2508 10.1056/NEJMoa033447 1:CAS:528:DC%2BD2cXhtVGksbnE 15590952 (Pubitemid 39603163)
23. A Varrone V Sansone MT Pellecchia M Amboni E Salvatore G De Michele, et al. 2008 Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [(123)I]FP-CIT Eur J Nucl Med Mol Imaging 35 7 1343 1349 10.1007/s00259-008-0729-x 18283454
24. AA Dobbeleir A-SE Hambÿe PR Franken 1999 Influence of high-energy photons on the spectrum of iodine-123 with low-and medium-energy collimators: consequences for imaging with 123I-labelled compounds in clinical practice Eur J Nucl Med Mol Imaging 26 6 655 10.1007/s002590050434 1:CAS:528: DyaK1MXjtFKitb8%3D (Pubitemid 29263637)
25. W Koch C Hamann J Welsch G Popperl PE Radau K Tatsch 2005 Is iterative reconstruction an alternative to filtered backprojection in routine processing of dopamine transporter SPECT studies? J Nucl Med 46 11 1804 1811 16269593
26. M Soret PM Koulibaly J Darcourt S Hapdey I Buvat 2003 Quantitative accuracy of dopaminergic neurotransmission imaging with (123)I SPECT J Nucl Med 44 7 1184 1193 1:CAS:528:DC%2BD3sXmtF2msbY%3D 12843235
27. JB Habraken J Booij P Slomka EB Sokole EA van Royen 1999 Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm J Nucl Med 40 7 1091 1097 1:STN:280:DyaK1Mzjt1Sisw%3D%3D 10405125
28. P Calvini G Rodriguez F Inguglia A Mignone UP Guerra F Nobili 2007 The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation Eur J Nucl Med Mol Imaging 34 8 1240 1253 10.1007/s00259-006-0357-2 17287959 (Pubitemid 47290660)
29. A Kas P Payoux M-O Habert Z Malek Y Cointepas G El Fakhri, et al. 2007 Validation of a standardized normalization template for statistical parametric mapping analysis of 123I-FP-CIT images J Nucl Med 48 9 1459 1467 10.2967/jnumed.106.038646 17704252 (Pubitemid 47397396)
30. W Koch PE Radau C Hamann K Tatsch 2005 Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies J Nucl Med 46 7 1109 1118 16000279
31. J Booij E Busemann Sokole MG Stabin AG Janssen K de Bruin EA van Royen 1998 Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters Eur J Nucl Med 25 1 24 30 10.1007/s002590050190 1:CAS:528:DyaK2sXnvVGru78%3D 9396871 (Pubitemid 28107900)
32. JT Kuikka KA Bergstrom A Ahonen E Lansimies 1994 The dosimetry of iodine-123 labelled 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane Eur J Nucl Med 21 1 53 56 10.1007/BF00182306 1:CAS:528:DyaK2cXlsFaiurc%3D 8088286
33. JP Seibyl E Wallace EO Smith M Stabin RM Baldwin S Zoghbi, et al. 1994 Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with iodine-123-beta-CIT in healthy human subjects J Nucl Med 35 5 764 770 1:CAS:528:DyaK2cXlsFahtL0%3D 8176456